Relating to human services; limiting the use of prior authorization under medical assistance (MA) programs for certain prescription drugs prescribed for the treatment of cancer, human immunodeficiency virus infection, acquired immunodeficiency syndrome or transplantation having no generically equivalent drug available under certain conditions
(je)